[PDF][PDF] Autologous, gene-modified hematopoietic stem and progenitor cells repopulate the central nervous system with distinct clonal variants
CW Peterson, JE Adair, ME Wohlfahrt, C Deleage… - Stem cell reports, 2019 - cell.com
… to target gene-modified cells to tissues. Gene-marked … and fluorescent bead uptake in
CD45+Lin–HLA-DR+ cells. We refer … -fluorescent staining with antibodies against GFP (green) and …
CD45+Lin–HLA-DR+ cells. We refer … -fluorescent staining with antibodies against GFP (green) and …
Hematopoietic gene therapies for metabolic and neurologic diseases
A Biffi - Hematology/Oncology Clinics, 2017 - hemonc.theclinics.com
… metabolic diseases affecting the central nervous system (CNS)… (ALS), receive hematopoietic
cell transplantation (HCT) from … The rationale for the use of HCT to treat these disorders is …
cell transplantation (HCT) from … The rationale for the use of HCT to treat these disorders is …
[HTML][HTML] … nanoparticles and an exogenous gene into the acutely inflamed brain tissue–evaluations on monocyte-based delivery system for the central nervous system
… Early studies using hematopoietic stem cell (HSC) … utilized to mediate the transfer of green
fluorescent protein (GFP) gene … more suitable to be used as cell vehicles targeting the brain …
fluorescent protein (GFP) gene … more suitable to be used as cell vehicles targeting the brain …
[HTML][HTML] Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
T Tsunogai, T Ohashi, Y Shimada, T Higuchi… - … Therapy-Methods & …, 2022 - cell.com
… ex vivo gene therapy targeting hematopoietic stem cells using a … activity in the central nervous
system and visceral organs. … EGFP fluorescence was observed in the cerebral cortex and …
system and visceral organs. … EGFP fluorescence was observed in the cerebral cortex and …
Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their …
… the central nervous system by improving neurological function, … However, given the diversity
of stem cells and disease targets… Green fluorescent protein is widely used as a reporter gene …
of stem cells and disease targets… Green fluorescent protein is widely used as a reporter gene …
[HTML][HTML] … marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological …
A Larochelle, MA Bellavance, JP Michaud… - Biochimica et Biophysica …, 2016 - Elsevier
… The central nervous system (CNS) is a very unique system … For an optimal reconstitution
of the hematopoietic system by … T cells were shown to target transplanted hematopoietic …
of the hematopoietic system by … T cells were shown to target transplanted hematopoietic …
Regulatable lentiviral hematopoietic stem cell gene therapy in a mouse model of Parkinson's disease
G Ge, C Chen, MJ Guderyon, J Liu, Z He… - Stem cells and …, 2018 - liebertpub.com
… circulating monocytes into the central nervous system (CNS). … The images were captured
with a fluorescent microscope (… to express and deliver GDNF to target neurons effectively. We …
with a fluorescent microscope (… to express and deliver GDNF to target neurons effectively. We …
[HTML][HTML] Gene-modified leucoconcentrate for personalized ex vivo gene therapy in a mini pig model of moderate spinal cord injury
RR Islamov, FV Bashirov, ME Sokolov… - Neural Regeneration …, 2021 - journals.lww.com
… and fluorescent microscopy studies of the gene-modified … The method was improved to use
hematopoietic stem cells (… of using leucocytes for targeted delivery of recombinant genes that …
hematopoietic stem cells (… of using leucocytes for targeted delivery of recombinant genes that …
Targeted gene addition at the CX3CR1 locus of human HSPCs improves their ability to repopulate the myeloid CNS compartment and drives lineage specific and …
… Cx3cr1-/+ versus WT cells within hematopoietic cell lineages … replace endogenous microglia
with gene modified MLCs upon … sections, we used a fluorescence microscope Delta Vision …
with gene modified MLCs upon … sections, we used a fluorescence microscope Delta Vision …
[HTML][HTML] Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation
… Among these tools, CRISPR-Cas9 has been widely adopted as it uses an RNA molecule
(gRNA) to target the nuclease (Cas9) to the desired genomic locus. Cas9 binding and the …
(gRNA) to target the nuclease (Cas9) to the desired genomic locus. Cas9 binding and the …